Literature DB >> 8047841

Familial macroglobulinaemia: hyperactive B-cells but normal natural killer function.

H M Ogmundsdóttir1, G M Jóhannesson, S Sveinsdóttir, S Einarsdóttir, A Hegeman, O Jensson, H M Ogsmundsdóttir.   

Abstract

An Icelandic family with two cases of benign monoclonal gammopathy and one case each of Waldenström's macroglobulinaemia, histiocytic lymphoma and multiple myeloma was first described in 1978. Nine family members had then shown raised values for se-IgM. Of these one has since died and another was not available for testing. In four of the remaining seven se-IgM had returned to normal; the three subjects who still showed raised se-IgM included the case of multiple myeloma diagnosed in 1985. Baseline production of IgM, IgG and Ig in vitro was normal in the 35 family members studied compared with 13 healthy control subjects, but the mean production of all immunoglobulin classes in response to minimal stimulation with PWM (1 microgram/ml) was significantly increased (P < 0.05). Ten family members showed markedly increased production of all three immunoglobulin classes (> 3 x SD above mean for controls). Raised production of IgM never occurred alone, indicating intact class switching. One family member showed extremely high values: IgA: 5.15 micrograms/ml, IgG: 16.3 micrograms/ml, IgM: 24.8 micrograms/ml (means for controls: 0.066, 0.123, 0.185 respectively). These 10 family members were of both sexes, ranged in age from 16 to 84 years and were clustered mainly in three distinct groups within the pedigree suggesting heredity. Proliferative responses to PWM were not significantly increased. Serum levels of interleukin-4 were tested in the patient with multiple myeloma and the family member with highest Ig production and found to be normal. We found no evidence for depressed NK function. Thus, in this family with a tendency for macroglobulinaemia and B cell derived malignancies B cell hyperreactivity was detectable by in vitro testing in several asymptomatic family members, of both sexes and all ages. No evidence was obtained for defects in regulatory mechanisms.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8047841     DOI: 10.1111/j.1365-3083.1994.tb03450.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  9 in total

1.  Enhanced B cell survival in familial macroglobulinaemia is associated with increased expression of Bcl-2.

Authors:  H M Ogmundsdóttir; S Sveinsdóttir; A Sigfússon; I Skaftadóttir; J G Jónasson; B A Agnarsson
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

Review 2.  Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies.

Authors:  Sigurdur Y Kristinsson; Lynn R Goldin; Magnus Björkholm; Jill Koshiol; Ingemar Turesson; Ola Landgren
Journal:  Haematologica       Date:  2009-07-07       Impact factor: 9.941

3.  Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia.

Authors:  Sigurdur Y Kristinsson; Jill Koshiol; Magnus Björkholm; Lynn R Goldin; Mary L McMaster; Ingemar Turesson; Ola Landgren
Journal:  J Natl Cancer Inst       Date:  2010-02-24       Impact factor: 13.506

4.  Differential characteristics of Waldenström macroglobulinemia according to patterns of familial aggregation.

Authors:  Regan H Royer; Jill Koshiol; Therese R Giambarresi; Linda G Vasquez; Ruth M Pfeiffer; Mary L McMaster
Journal:  Blood       Date:  2010-03-22       Impact factor: 22.113

Review 5.  Etiology of Waldenström macroglobulinemia: genetic factors and immune-related conditions.

Authors:  Elisabet E Manasanch; Sigurdur Y Kristinsson; Ola Landgren
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2013-03-07

6.  Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden.

Authors:  Sigurdur Y Kristinsson; Magnus Björkholm; Lynn R Goldin; Mary L McMaster; Ingemar Turesson; Ola Landgren
Journal:  Blood       Date:  2008-08-13       Impact factor: 22.113

Review 7.  Genetics- and immune-related factors in the pathogenesis of lymphoplasmacytic lymphoma/ Waldenström's macroglobulinemia.

Authors:  Sigurdur Y Kristinsson; Jill Koshiol; Lynn R Goldin; Magnus Björkholm; Ingemar Turesson; Gloria Gridley; Mary L McMaster; Ola Landgren
Journal:  Clin Lymphoma Myeloma       Date:  2009-03

8.  Inherited polymorphisms in hyaluronan synthase 1 predict risk of systemic B-cell malignancies but not of breast cancer.

Authors:  Hemalatha Kuppusamy; Helga M Ogmundsdottir; Eva Baigorri; Amanda Warkentin; Hlif Steingrimsdottir; Vilhelmina Haraldsdottir; Michael J Mant; John Mackey; James B Johnston; Sophia Adamia; Andrew R Belch; Linda M Pilarski
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

Review 9.  Waldenström macroglobulinemia: clinical and immunological aspects, natural history, cell of origin, and emerging mouse models.

Authors:  Siegfried Janz
Journal:  ISRN Hematol       Date:  2013-09-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.